U.S. Markets close in 5 hrs 9 mins

Boston Scientific reports favorable results of Re-ROUTE trial

The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the legs, the company said. The data from the Re-ROUTE clinical trial were reported today in a late-breaking clinical trial session at the Vascular Interventional Advances Conference in Las Vegas. In the Re-ROUTE trial, investigators were successful in navigating around challenging CTOs in the enrolled trial patients 84.8% of the time using the OffRoad device, exceeding the pre-specified trial goals.